Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

Gruppo Italiano Malattie EMatologiche dell'Adulto

Status: Unknown

Conditions: Acute Promyelocytic Leukemia

Treatments: Other: QoL questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT03096496

QoL-APL0816

Details and patient eligibility

About

This is a prospective and international observational study run by the GIMEMA. All data will be centrally collected and analyzed at the GIMEMA Data Center in Rome (Italy). Patients reported outcomes will be collected using internationally validated questionnaires.

Enrollment: 161 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• APL survivors enrolled in GIMEMA APL0406 clinical trial and in first molecular CR after third consolidation treatment
• Written informed consent.

Exclusion criteria

• APL patients previously enrolled in GIMEMA APL0406 trial who cannot be reached or who are lost to follow-up.

Trial design

161 participants in 1 patient group

GIMEMA APL0406 patients

Description:

APL survivors previously enrolled in GIMEMA APL0406 clinical trial and in 1st molecular CR after third consolidation treatment.

Treatment:

Other: QoL questionnaires